Filing Details
- Accession Number:
- 0001181431-12-052508
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-01 16:39:53
- Reporting Period:
- 2012-09-27
- Filing Date:
- 2012-10-01
- Accepted Time:
- 2012-10-01 16:39:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 275053 | Natures Sunshine Products Inc | NATR | Pharmaceutical Preparations (2834) | 870327982 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1374566 | Willem Mesdag | 10100 Santa Monica Boulevard Suite 925 Los Angeles CA 90067 | Yes | No | Yes | No | |
| 1374588 | Red Mountain Capital Partners Llc | 10100 Santa Monica Boulevard Suite 925 Los Angeles CA 90067 | No | No | Yes | No | |
| 1374600 | Red Mountain Capital Partners Iii, L.p. | 10100 Santa Monica Boulevard Suite 925 Los Angeles CA 90067 | No | No | No | Yes | |
| 1374602 | Red Mountain Capital Partners Ii, L.p. | 10100 Santa Monica Boulevard Suite 925 Los Angeles CA 90067 | No | No | No | Yes | |
| 1374606 | Rmcp Gp Llc | 10100 Santa Monica Boulevard Suite 925 Los Angeles CA 90067 | No | No | Yes | No | |
| 1374607 | Red Mountain Capital Management Inc | 10100 Santa Monica Boulevard Suite 925 Los Angeles CA 90067 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-09-27 | 233,700 | $16.29 | 1,398,866 | No | 4 | P | Indirect | See footnote 2 and Remarks below. |
| Common Stock | Acquisiton | 2012-09-28 | 18,200 | $16.26 | 1,417,066 | No | 4 | P | Indirect | See footnote 2 and Remarks below. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote 2 and Remarks below. |
| No | 4 | P | Indirect | See footnote 2 and Remarks below. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 562,424 | Indirect | See footnote 4 and Remarks below. |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (right to buy) | $5.35 | 2009-11-06 | 2019-09-24 | 25,000 | 25,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2019-09-24 | 25,000 | 25,000 | Direct |
Footnotes
- Weighted average of shares acquired in open-market transactions on September 27, 2012. Red Mountain Capital Partners LLC hereby undertakes to provide full information regarding the number of shares and prices at which those trades were effected upon request by the SEC staff, the issuer, or a securityholder of the issuer.
- These shares are held directly by Red Mountain Capital Partners II, L.P. ("RMCP II").
- Weighted average of shares acquired in open-market transactions on September 28, 2012. Red Mountain Capital Partners LLC hereby undertakes to provide full information regarding the number of shares and prices at which those trades were effected upon request by the SEC staff, the issuer, or a securityholder of the issuer.
- These shares are held directly by Red Mountain Capital Partners III, L.P. ("RMCP III").
Billionaire Hedge Funds
